COVID-19 vaccines: under evaluation
The European Medicines Agency (EMA) is evaluating potential COVID-19 vaccines to enable the distribution of promising vaccines in the European Union (EU) as soon as possible.
|Vaccine||Vaccine developer||Start of rolling review||More information|
Novavax CZ AS
|Sputnik V (Gam-COVID-Vac)||Russia’s Gamaleya National Centre of Epidemiology and Microbiology||04/03/2021||EMA starts rolling review of the Sputnik V COVID-19 vaccine|
|COVID-19 Vaccine (Vero Cell) Inactivated||Sinovac Life Sciences Co., Ltd||04/05/2021||EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated|
For more information on the expedited evaluation procedure EMA is applying for COVID-19 vaccines, including the rolling review, see:
For more information on the expedited evaluation procedure EMA is applying for COVID-19 vaccines, including the conditional marketing authorisation, see: